In a significant move that aims to revolutionize its IT operations, Alnylam Pharmaceuticals Inc. has entered into a strategic collaboration with Cognizant. This partnership is designed to both transform and scale Alnylam’s global infrastructure, cloud, security, platforms, applications, and advanced data analytics capabilities. Cognizant, serving as Alnylam’s IT Managed Services provider, will be responsible for managing all aspects of the biopharmaceutical company’s IT landscape. By leveraging Cognizant’s extensive managed services frameworks and its proven experience with large pharmaceutical companies, this collaboration aims to enhance automation, reduce operational efforts, and foster greater transparency in Alnylam’s business decisions.
Accelerated Business Outcomes and Customer Experience
In a groundbreaking move to transform its IT operations, Alnylam Pharmaceuticals Inc. has formed a strategic partnership with Cognizant. This collaboration is focused on overhauling and expanding Alnylam’s global infrastructure, covering areas such as cloud computing, cybersecurity, platforms, applications, and advanced data analytics. Cognizant will take on the role of Alnylam’s IT Managed Services provider, managing every facet of the biopharmaceutical company’s IT landscape. Leveraging Cognizant’s comprehensive managed services frameworks and its extensive experience with large pharmaceutical firms, this partnership aims to boost automation, minimize operational effort, and increase transparency in Alnylam’s business decision-making processes. The collaboration seeks to support Alnylam in achieving more streamlined operations, better security measures, and improved data-driven insights, thereby significantly enhancing the company’s overall efficiency and effectiveness. With Cognizant’s expertise, Alnylam aspires to set new industry standards in technology management and operational excellence in the biopharmaceutical sector.
